Preclinical evaluation of 111In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts.
暂无分享,去创建一个
I. Pastan | M. Brechbiel | J. Carrasquillo | K. Garmestani | O. Gansow | S. Kinuya | L. Camera | L. Pai | C. Paik
[1] M. Brechbiel,et al. Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labelling of monoclonal antibodies with the bismuth-212 α-particle emitter , 1992 .
[2] I. Pastan,et al. Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. , 1991, Cancer research.
[3] S. Larson,et al. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] I. Pastan,et al. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[5] S. Mirzadeh,et al. Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[6] P. Bunn,et al. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts. , 1990, Cancer research.
[7] D. Goldenberg,et al. Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] M. Brechbiel,et al. Selection of a dtpa chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice , 1990, International journal of cancer.
[9] K. Hellström,et al. Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. , 1990, Cancer research.
[10] S. Larson. Clinical radioimmunodetection, 1978-1988: overview and suggestions for standardization of clinical trials. , 1990, Cancer research.
[11] K. Klein,et al. Patterns of antigen distribution in human carcinomas. , 1990, Cancer research.
[12] R K Jain,et al. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. , 1990, Cancer research.
[13] S. Larson,et al. Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting. , 1990, Cancer research.
[14] Y. S. Kim,et al. 17 – Carbohydrate Tumor Markers in Colon Cancer and Polyps , 1990 .
[15] S. Mirzadeh,et al. Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin. , 1990, Bioconjugate chemistry.
[16] M. Brechbiel,et al. Improved sarcoma imaging and reduced hepatic activity with indium-111-SCN-Bz-DTPA linked to MoAb 19-24. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] J. Murray,et al. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] R. Bast,et al. Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody. , 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[19] D. E. Simpson,et al. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] S. Pestka,et al. Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo. , 1987, Science.
[21] B. Gallagher,et al. Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In. , 1987, Cancer research.
[22] R. Dillman,et al. Problems associated with radioimmunodetection and possibilities for future solutions. , 1987, Journal of biological response modifiers.
[23] D. E. Simpson,et al. Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies , 1986 .
[24] S. Hakomori,et al. Differential expression of difucosyl type 2 chain (LeY) defined by monoclonal antibody AH6 in different locations of colonic epithelia, various histological types of colonic polyps, and adenocarcinomas. , 1986, Cancer research.
[25] F. Buchegger,et al. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. , 1986, The Journal of clinical investigation.
[26] D. Carlo,et al. In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] P. Bunn,et al. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. , 1984, Journal of immunological methods.
[28] D. Solter,et al. Tumor radioimmunolocation: differential antibody retention by antigenic normal tissue and tumor. , 1984, Journal of immunology.
[29] J. Douillard,et al. Immunoscintigraphy of colon carcinoma. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] C. Mulhern,et al. Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments. , 1983, Radiology.
[31] J. Koziol,et al. Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. , 1983, Cancer research.
[32] R. Wahl,et al. Improved radioimaging and tumor localization with monoclonal F(ab')2. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] W. Bodmer,et al. TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS , 1982, The Lancet.
[34] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.